NASDAQ:AHCO AdaptHealth (AHCO) Stock Price, News & Analysis $11.22 -0.31 (-2.69%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$11.09▼$11.6650-Day Range$9.28▼$11.6052-Week Range$6.37▼$15.37Volume832,390 shsAverage Volume1.05 million shsMarket Capitalization$1.49 billionP/E RatioN/ADividend YieldN/APrice Target$10.70 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get AdaptHealth alerts: Email Address AdaptHealth MarketRank™ Stock AnalysisAnalyst RatingHold2.40 Rating ScoreUpside/Downside4.6% Downside$10.70 Price TargetShort InterestBearish10.88% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.76Based on 8 Articles This WeekInsider TradingN/AProj. Earnings Growth23.17%From $0.82 to $1.01 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.35 out of 5 starsMedical Sector802nd out of 936 stocksHome Health Care Services Industry6th out of 8 stocks 1.2 Analyst's Opinion Consensus RatingAdaptHealth has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 3 buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageAdaptHealth has only been the subject of 1 research reports in the past 90 days.Read more about AdaptHealth's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted10.88% of the float of AdaptHealth has been sold short.Short Interest Ratio / Days to CoverAdaptHealth has a short interest ratio ("days to cover") of 9.Change versus previous monthShort interest in AdaptHealth has recently increased by 4.33%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldAdaptHealth does not currently pay a dividend.Dividend GrowthAdaptHealth does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AHCO. Previous Next 3.2 News and Social Media Coverage News SentimentAdaptHealth has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for AdaptHealth this week, compared to 3 articles on an average week.MarketBeat Follows2 people have added AdaptHealth to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, AdaptHealth insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.43% of the stock of AdaptHealth is held by insiders.Percentage Held by Institutions82.67% of the stock of AdaptHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about AdaptHealth's insider trading history. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for AdaptHealth are expected to grow by 23.17% in the coming year, from $0.82 to $1.01 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of AdaptHealth is -2.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of AdaptHealth is -2.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioAdaptHealth has a PEG Ratio of 0.78. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioAdaptHealth has a P/B Ratio of 1.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about AdaptHealth's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Traders Agency5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here.Click here to pay just $5 for a full year of Stealth Trades About AdaptHealth Stock (NASDAQ:AHCO)AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.Read More AHCO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AHCO Stock News HeadlinesJuly 24 at 3:31 AM | americanbankingnews.comStock Traders Buy High Volume of Call Options on AdaptHealth (NASDAQ:AHCO)July 19, 2024 | markets.businessinsider.comAdaptHealth Poised for Growth: Strong Q2 Outlook and Strategic Leadership Underpin Buy RatingJuly 26, 2024 | Weiss Ratings (Ad)Nvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.July 17, 2024 | americanbankingnews.comAdaptHealth Corp. (NASDAQ:AHCO) Short Interest Up 5.6% in JuneJune 10, 2024 | globenewswire.comThe Portnoy Law Firm Announces Investigation of AdaptHealth Corp. (NASDAQ: AHCO)June 7, 2024 | globenewswire.comThe Portnoy Law Firm Announces Investigation of AdaptHealth Corp. (NASDAQ: AHCO)May 29, 2024 | msn.comAdaptHealth to Present at Jefferies Global Healthcare ConferenceMay 29, 2024 | msn.comAdaptHealth Grants Stock Units to New CEO Suzanne FosterJuly 26, 2024 | Weiss Ratings (Ad)Nvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.May 29, 2024 | msn.comAdaptHealth to Join UBS Healthcare SummitMay 28, 2024 | msn.comAdaptHealth to Showcase Home Healthcare Solutions at ConferenceMay 22, 2024 | finance.yahoo.comAdaptHealth Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)May 22, 2024 | businesswire.comAdaptHealth Corp. to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceMay 22, 2024 | businesswire.comAdaptHealth Corp. to Participate in the Jefferies Global Healthcare ConferenceMay 22, 2024 | businesswire.comAdaptHealth Corp. to Participate in the UBS Healthcare Services Cape Cod SummitMay 20, 2024 | businesswire.comAdaptHealth Corp. to Participate in the 2024 Leerink Partners Healthcare Crossroads ConferenceMay 16, 2024 | markets.businessinsider.comAdaptHealth Growth Concerns Prompt Underperform Rating Amid Operational ChallengesMay 15, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: AdaptHealth (AHCO), Allogene Therapeutics (ALLO)See More Headlines Receive AHCO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AdaptHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/07/2024Today7/26/2024Next Earnings (Confirmed)8/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Home health care services Sub-IndustryHealthcare Current SymbolNASDAQ:AHCO CUSIPN/A CIK1725255 Webwww.adapthealth.com Phone(610) 424-4515FaxN/AEmployees10,700Year FoundedN/APrice Target and Rating Average Stock Price Target$10.70 High Stock Price Target$13.00 Low Stock Price Target$6.50 Potential Upside/Downside-4.1%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($5.27) Trailing P/E RatioN/A Forward P/E Ratio13.61 P/E Growth0.78Net Income$-678,900,000.00 Net Margins-21.45% Pretax Margin-22.58% Return on Equity8.47% Return on Assets3.07% Debt Debt-to-Equity Ratio1.48 Current Ratio1.33 Quick Ratio1.11 Sales & Book Value Annual Sales$3.20 billion Price / Sales0.46 Cash Flow$10.33 per share Price / Cash Flow1.08 Book Value$11.06 per share Price / Book1.01Miscellaneous Outstanding Shares133,200,000Free Float127,301,000Market Cap$1.49 billion OptionableOptionable Beta1.10 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Joshua Parnes (Age 45)President & Director Comp: $1.33MMr. Jason A. Clemens C.F.A. (Age 45)Chief Financial Officer Comp: $1.13MKey CompetitorsLHC GroupNASDAQ:LHCGOption Care HealthNASDAQ:OPCHPACS GroupNYSE:PACSHims & Hers HealthNYSE:HIMSGuardant HealthNASDAQ:GHView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 20,599 shares on 7/26/2024Ownership: 0.560%Allspring Global Investments Holdings LLCBought 11,258 shares on 7/26/2024Ownership: 0.008%SummerHaven Investment Management LLCBought 1,503 shares on 7/24/2024Ownership: 0.043%Louisiana State Employees Retirement SystemSold 1,200 shares on 7/24/2024Ownership: 0.030%Blue Trust Inc.Bought 8,520 shares on 7/18/2024Ownership: 0.006%View All Insider TransactionsView All Institutional Transactions AHCO Stock Analysis - Frequently Asked Questions How have AHCO shares performed this year? AdaptHealth's stock was trading at $7.29 at the beginning of the year. Since then, AHCO shares have increased by 53.9% and is now trading at $11.22. View the best growth stocks for 2024 here. How were AdaptHealth's earnings last quarter? AdaptHealth Corp. (NASDAQ:AHCO) issued its quarterly earnings data on Tuesday, May, 7th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by $0.04. The business earned $792.50 million during the quarter, compared to analyst estimates of $771.08 million. AdaptHealth had a positive trailing twelve-month return on equity of 8.47% and a negative net margin of 21.45%. Who are AdaptHealth's major shareholders? AdaptHealth's top institutional investors include Reinhart Partners LLC. (3.21%), Bank of New York Mellon Corp (0.56%), LGT Capital Partners LTD. (0.24%) and Harbor Capital Advisors Inc. (0.14%). Insiders that own company stock include Everest Hill Group Inc, Skyknight Capital Fund Ii, LP, Skyknight Aero Holdings, Llc, Aero Holdings Ii Ll Skyknight, Jason A Clemens, Daniel Bunting, Shaw Rietkerk, Albert A Prast, Christopher J Joyce, David Solomon Williams III, Frank Mullen and Stephen P Griggs. View institutional ownership trends. How do I buy shares of AdaptHealth? Shares of AHCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of AdaptHealth own? Based on aggregate information from My MarketBeat watchlists, some other companies that AdaptHealth investors own include Advanced Micro Devices (AMD), Johnson & Johnson (JNJ), Advance Auto Parts (AAP), American International Group (AIG), Biogen (BIIB), BioMarin Pharmaceutical (BMRN) and Bristol-Myers Squibb (BMY). This page (NASDAQ:AHCO) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdaptHealth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share AdaptHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
